Results of a new study offer preliminary evidence that blood tests could select patients for treatment, and track response and resistance.
Liquid biopsy tests of circulating DNA could guide prostate cancer treatment, the Guardian reports.
Two new studies have delivered a multitude of new markers linked to testicular cancer, as well as a better understanding of the genetic architecture of the disease.
New data points to strong predictive ability for a ddPCR-based test of AR copy number, while other companies are pursuing tests that target expression of AR splice variants.
Exome sequencing data for hundreds of testicular germ cell tumor patients led to the discovery of rare mutations affecting cilia-microtubule genes.
Sequencing the exomes of more than 1,000 individuals with familial colorectal cancer revealed rare variants in several new candidate risk genes.
The researchers plan to enroll 400 patients in the pilot, with the goal of increasing the availability of targeted therapies to pediatric cancer patients.
Researchers identified a germline variant on chromosome 6 that corresponded to overall survival times in multiple myeloma patients from four study cohorts.
Combining the new risk variants with those found in the past, researchers came up with a risk score that may eventually help find those most susceptible to the disease.
An Institute of Cancer Research-led team conducted a meta-analysis that uncovered five new variants linked to glioma development, including one that greatly increases risk of glioblastoma.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.